Cargando…
Health technology assessment in middle-income countries: recommendations for a balanced assessment system
Because of significant differences in institutional contexts, health technology assessment (HTA) systems that are in place in core pharmaceutical markets may not be suitable, fully or in part, for middle-income countries (MICs) and for other noncore markets. Particular challenges may arise when syst...
Autor principal: | Dankó, Dávid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865748/ https://www.ncbi.nlm.nih.gov/pubmed/27226832 http://dx.doi.org/10.3402/jmahp.v2.23181 |
Ejemplares similares
-
Health technology assessment in the Balkans: opportunities for a balanced drug assessment system
por: Dankó, Dávid, et al.
Publicado: (2014) -
How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review
por: Falkowski, Anna, et al.
Publicado: (2022) -
Systematic Literature Review of Health Impact Assessments in Low and Middle-Income Countries
por: Thondoo, Meelan, et al.
Publicado: (2019) -
Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries
por: Nemzoff, Cassandra, et al.
Publicado: (2021) -
Balanced assessment systems revisited
por: Dankó, Dávid, et al.
Publicado: (2017)